Core Scientific upgraded on its uncontracted power capacity

Market Intelligence Analysis

AI-Powered 80% GROQ-LLAMA-3.1-8B-INSTANT
Why This Matters

Roth MKM upgraded Core Scientific to Buy, expecting the merger with CoreWeave to be rejected without renegotiation, citing growing shareholder opposition and proxy advisers' recommendations against the deal.

Market Impact

Positive, as the upgrade and increased price target of $23.50 may lead to a short-term increase in Core Scientific's stock price, potentially benefiting investors who hold the stock.

Sentiment
Bullish
AI Confidence
80%

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

Investing.com --Roth MKM upgraded Core Scientific to Buy saying it now expects the data center operator’s merger with CoreWeave to be rejected without renegotiation and sees value in its uncontracted power capacity.Roth lifted its price target to $23.50 from $17. There is growing shareholder opposition against deal and CoreWeave’s insistence that its offer was “best and final” have made the deal unlikely to close. Proxy advisers Glass Lewis and ISS have also recommended against it. The firms are

Continue Reading
Full article on Unknown
Read Full Article
AI Breakdown

Summary

Roth MKM upgraded Core Scientific to Buy, expecting the merger with CoreWeave to be rejected without renegotiation, citing growing shareholder opposition and proxy advisers' recommendations against the deal.

Market Impact

Positive, as the upgrade and increased price target of $23.50 may lead to a short-term increase in Core Scientific's stock price, potentially benefiting investors who hold the stock.

Original article published by Unknown on October 23, 2025.
Analysis and insights provided by AnalystMarkets AI.